Qualcomm files patent lawsuit against Apple in China seeking to ban the sale and manufacture of iPhones
Chipmaker files patent suit against its customer in China — Suit will seek ban of sale, manufacturing of offending devices — Qualcomm Inc. filed lawsuits in China seeking to ban …
Context & Ripple Effects
This suit extends a playbook Qualcomm has run in China before: it filed patent infringement suits against Meizu in Chinese courts in 2016 to force that phone maker into a licensing agreement. The difference now is scale and target — the defendant is Qualcomm's largest customer, and the remedy sought touches both sale and manufacture of iPhones inside the country where they are assembled.
The escalation has been building all year: in May, [[a:919060|Qualcomm sued iPhone assemblers Compal, Foxconn, Pegatron, and Wistron over unpaid royalties]], and weeks after this filing it added three more U.S. complaints seeking an ITC import ban on iPhones using Intel chips. Apple's later court filing arguing that the resulting China ban would force a settlement shows how much leverage these suits ultimately created.
First-order effects
- Apple faces a credible threat to both selling iPhones in China — one of its largest markets — and manufacturing them there, since the suits seek bans on sale and manufacture of offending devices.
- Qualcomm converts a stalled licensing negotiation with its biggest customer into courtroom leverage, moving the dispute from contract talks to remedies that can halt product flow.
Second-order effects
- The assemblers Qualcomm already sued — Compal, Foxconn, Pegatron, Wistron — are squeezed between royalty claims from their chip supplier and pressure from their customer, making the contract manufacturers the transmission point of the fight.
- With Qualcomm simultaneously pursuing an ITC ban on iPhones using Intel chips, Apple must defend the same product line on two regulatory fronts, raising the cost of holding out on licensing terms.
Third-order effects
- If the pattern holds, patent litigation becomes a standard instrument for extracting device royalties rather than a last resort — with handset makers' exposure determined by where they manufacture and sell, not just where they are incorporated.
- China's courts functioning as an enforcement venue for a U.S. chip-licensing dispute signals that jurisdiction choice itself is now strategic in global component negotiations, with each side forum-shopping for maximum disruption.
The trend: Mobile-silicon licensing disputes are shifting from negotiated royalties to multi-jurisdiction litigation designed to interrupt product supply, with Qualcomm's China and ITC actions as the leading edge.